Industry Satellite Symposia
Switch To Module
ESMO Congress 2021 - Conference Calendar
On-demand Educational sessions
On-demand Special Symposia
On-demand Multidisciplinary sessions
On-demand ePosters
Industry Satellite Symposia
Digital Evaluations
Everything
Everything
Session Title
Session Number
Presentation Title
Presentation Number
Author
Presenter
Chair
Filter By
Day
Select All
Deselect All
Fri, 17.09.2021
12
Sat, 18.09.2021
11
Sun, 19.09.2021
12
Mon, 20.09.2021
11
Tue, 21.09.2021
11
Room
Select All
Deselect All
Channel 3
14
Channel 4
15
Channel 5
13
Channel 6
15
Session Type
Select All
Deselect All
Industry Satellite Symposium
57
Presentation Type
Select All
Deselect All
Invited Speaker
57
Presentation Topic
Select All
Deselect All
General interest
57
Cancel
Clear
Search
Advanced Search
Sign in
Scheduled sessions
On-demand Educational sessions
On-demand Special Symposia
On-demand Multidisciplinary sessions
On-demand ePosters
Industry Satellite Symposia
Final Programme PDF
Browsing Over 57 Sessions
Sort By
Session Datetime
Upcoming First
Relevance
Session Number
Session Datetime
MSD - Homologous Recombination Deficiency: BRCA and beyond
(ID 99)
Time
08:45 - 09:50
Servier - The clinical value of mIDH1 inhibition in cholangiocarcinoma
(ID 100)
Time
08:45 - 10:15
Illumina - Profiling Non-Small Cell Lung Cancer using Comprehensive Genomic Profiling
(ID 98)
Time
08:45 - 10:15
AstraZeneca - From Breast Cancer Biology to Therapy
(ID 101)
Time
08:45 - 10:15
AstraZeneca - Re-evaluating the role of gBRCA in breast cancer
(ID 104)
Time
10:30 - 12:00
ITM Isotopen Technologien München AG - A Global Perspective on the Management of Neuroendocrine Tumors – the Evolving Role of Targeted Radionuclide Diagnostics and Therapy
(ID 102)
Time
10:30 - 12:00
Novartis - Unmet needs in oncogene-driven NSCLC: how do we close the gap?
(ID 105)
Time
10:30 - 12:00
MSD - The Role of Biomarkers in Patient Management in Immuno-Oncology
(ID 103)
Time
10:30 - 11:30
Merck - Current and future treatments for head and neck cancer
(ID 109)
Time
18:45 - 20:15
Medscape - A Stepwise Approach To Managing HR+/HER2- Early Breast Cancer: From Risk Assessment To Risk Management
(ID 107)
Time
18:45 - 20:15
Bayer - Taking action in nmCRPC: Cases in the clinic
(ID 108)
Time
18:45 - 20:15
MSD - Evolving Treatment Landscape in HNSCC
(ID 106)
Time
18:45 - 20:15